Department of Experimental Psychology, University of Oxford, Oxford, Oxfordshire, UK.
Neuropsychopharmacology. 2011 Jan;36(1):114-32. doi: 10.1038/npp.2010.165. Epub 2010 Sep 29.
Neurophysiological experiments in primates, alongside neuropsychological and functional magnetic resonance investigations in humans, have significantly enhanced our understanding of the neural architecture of decision making. In this review, I consider the more limited database of experiments that have investigated how dopamine and serotonin activity influences the choices of human adults. These include those experiments that have involved the administration of drugs to healthy controls, experiments that have tested genotypic influences upon dopamine and serotonin function, and, finally, some of those experiments that have examined the effects of drugs on the decision making of clinical samples. Pharmacological experiments in humans are few in number and face considerable methodological challenges in terms of drug specificity, uncertainties about pre- vs post-synaptic modes of action, and interactions with baseline cognitive performance. However, the available data are broadly consistent with current computational models of dopamine function in decision making and highlight the dissociable roles of dopamine receptor systems in the learning about outcomes that underpins value-based decision making. Moreover, genotypic influences on (interacting) prefrontal and striatal dopamine activity are associated with changes in choice behavior that might be relevant to understanding exploratory behaviors and vulnerability to addictive disorders. Manipulations of serotonin in laboratory tests of decision making in human participants have provided less consistent results, but the information gathered to date indicates a role for serotonin in learning about bad decision outcomes, non-normative aspects of risk-seeking behavior, and social choices involving affiliation and notions of fairness. Finally, I suggest that the role played by serotonin in the regulation of cognitive biases, and representation of context in learning, point toward a role in the cortically mediated cognitive appraisal of reinforcers when selecting between actions, potentially accounting for its influence upon the processing salient aversive outcomes and social choice.
神经生理学实验在灵长类动物中,以及神经心理学和功能磁共振成像在人类中的研究,极大地提高了我们对决策的神经结构的理解。在这篇综述中,我考虑了那些研究多巴胺和血清素活性如何影响人类成年人选择的实验数据库较为有限。这些实验包括那些给健康对照者给药的实验,那些测试多巴胺和血清素功能的遗传影响的实验,以及最后一些检查药物对临床样本决策的影响的实验。人类的药理学实验数量较少,在药物特异性、前后突触作用模式的不确定性以及与基线认知表现的相互作用方面面临相当大的方法学挑战。然而,可用的数据与当前决策中多巴胺功能的计算模型广泛一致,并强调了多巴胺受体系统在学习结果中的可分离作用,这些结果是基于价值的决策。此外,(相互作用的)前额叶和纹状体多巴胺活动的遗传影响与选择行为的变化有关,这些变化可能与理解探索性行为和对成瘾障碍的易感性有关。在人类参与者的决策实验室测试中对血清素的操纵提供了不一致的结果,但迄今为止收集的信息表明,血清素在学习不良决策结果、风险寻求行为的非规范方面以及涉及联系和公平观念的社会选择中发挥作用。最后,我认为血清素在调节认知偏差和学习中的情境表示中的作用指向了在选择行动之间调节强化物的皮层介导认知评估中的作用,可能解释了它对处理突出的厌恶结果和社会选择的影响。